Delivery Order SPE2DB24D3014-SPE2DB25FKUGS
Award Date 8/11/25
Potential Completion Date 8/12/25
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $9,132.68 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes on August 11, 2025, with an ultimate completion date of August 12, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. TREMFYA is a prescription biologic medication used to treat moderate to severe plaque psoriasis and...
- The Defense Logistics Agency awarded a $19,499.34 delivery order to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes on September 3, 2025, with completion scheduled for September 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. TREMFYA is a prescription biologic medication used to treat moderate to severe plaque psoriasis and other inflammatory conditions,...
- The Defense Logistics Agency awarded a $59,710.11 delivery order to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes, with performance to be completed by July 31, 2025. This is a firm fixed price, non-competitive delivery order executed on July 30, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order valued at $15,468.22 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes. The contract, executed on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a firm fixed price delivery order with no set-aside designation. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $14.5K delivery order to AmerisourceBergen Drug Corp for TREMFYA 200 mg/2 ml syringes on August 25, 2025, with an ultimate completion date of September 16, 2025. This is a firm fixed-price, non-set-aside contract that represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99M through December 2026. TREMFYA is a specialty pharmaceutical product used primarily for treating...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes valued at $7,683.48 on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price contract represents a non-competitive, non-set-aside award to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. TREMFYA is a specialty immunosuppressant injection used to treat psoriasis and psoriatic arthritis, reflecting the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $22,624.36 for TREMFYA 100 mg/mL syringes on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. TREMFYA (guselkumab) is a monoclonal antibody used to treat moderate to severe plaque psoriasis and other...
- The Defense Logistics Agency awarded a $29,944.86 delivery order to AmerisourceBergen Drug Corp for TREMFYA 100 mg/mL pharmaceutical product on August 7, 2025, with completion scheduled for August 8, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and specifies performance at the contractor's Conshohocken, Pennsylvania facility. TREMFYA is a biologic medication used primarily for treating moderate-to-severe plaque psoriasis and is being procured to...
- The Defense Logistics Agency awarded a $44,134.83 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of TREMFYA 100 MG/ML syringes. The contract, which is scheduled for completion by July 21, 2025, represents a competitively awarded purchase with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a primary pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $7,269.70 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of TREMFYA 200 mg/2 ml syringes. This competitive, non-set-aside contract has a firm fixed price structure with an ultimate completion date of September 4, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. TREMFYA is a prescription biologic medication used in the treatment of plaque psoriasis and psoriatic arthritis, and...